eBook, PDF

Alcoholic and Non-Alcoholic Fatty Liver Disease (eBook, PDF)

Bench to Bedside

Redaktion: Chalasani, Naga; Szabo, Gyongyi

Beschreibung

This volume is the first text to concisely yet comprehensively cover developments for both alcoholic and nonalcoholic fatty liver disease in an organized fashion. Aspects of these two diseases covered in the book include global epidemiology and risk factors, pathogenesis, animal models, hepatic and extra-hepatic malignancies, treatment models, and current and emerging therapies.

Written by experts in the field, Alcoholic and Non-Alcoholic Fatty Liver Disease: Bench to Bedside is a valuable resource for gastroenterologists, pathologists, and hepatologists who treat patients with alcoholic and nonalcoholic fatty liver disease.

Technische Details

• Geräte: PC
• ohne Kopierschutz
• Größe: 12.97MB

Barrierefreiheit

• Text-to-Speech

Autor

Drs. Chalasani and Szabo are senior investigators in the field of fatty liver disease and have had extensive federal funding to investigate these areas. They both hold leadership positions and are recognized as experts in the field of fatty liver disease. For example, Dr. Chalasani is the lead author of the multi-society practice guideline on the diagnosis and management of nonalcoholic fatty liver disease& Dr. Szabo is the president-elect of the American Association for the Study of Liver Disease which is the largest liver society in the world. They are also actively practicing clinicians and thus aware of clinically relevant knowledge gaps in the field.

Produktdetails

• Verlag: Springer International Publishing
• Seitenzahl: 372
• Erscheinungstermin: 10. Dezember 2015
• Englisch
• ISBN-13: 9783319205380
• Artikelnr.: 44485833

Rezensionen

"The purpose is to serve as a review of both mechanisms of liver disease. The book is meant to compare the two unique diseases, which share several mechanisms. ... The book summarizes current knowledge and contains updates on recent research. ... This is a high quality resource on the topic of alcoholic and nonalcoholic fatty liver disease, providing an in-depth discussion of the mechanisms ... ." (Ryan R. Sefcik, Doody's Book Reviews, June, 2016)